Strive Financial Group’s Biogen BIIB Stock Holding History

Strive Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$5K	–	897
2026 Q1	$5K	Buy	+2	New	+$369	﹤0.01%	504

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Strive Financial Group's BIIB Position: Q2 2026 in Review

Strive Financial Group held its Biogen (BIIB) position steady in Q2 2026 at 200 shares worth $43.2K. The position accounts for 0.02% of the portfolio, ranked #293.

Strive Financial Group first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 684 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Strive Financial Group held 200 shares of Biogen worth $43.2K as of Q2 2026.
Strive Financial Group left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.02% of Strive Financial Group's portfolio in Q2 2026, its #293 holding.
Strive Financial Group first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
684 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.